COPD pharmacology

Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis
Yuji Oba, Siva T Sarva, Sofia Dias

Thorax Jan 2016, 71 (1) 15-25; DOI: 10.1136/thoraxjnl-2014-206732
Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility)
Irene J Higginson, Andrew Wilcock, Miriam J Johnson, Sabrina Bajwah, Natasha Lovell, Deokhee Yi, Simon P Hart, Vincent Crosby, Heather Poad, David Currow, Emma Best, Sarah Brown

Thorax Feb 2020, 75 (2) 176-179; DOI: 10.1136/thoraxjnl-2019-213879
Critical role of fractalkine (CX₃CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium
Cristina Rius, Chantal Company, Laura Piqueras, Jose Miguel Cerdá-Nicolás, Cruz González, Emilio Servera, Andreas Ludwig, Esteban J Morcillo, Maria-Jesus Sanz

Thorax Feb 2013, 68 (2) 177-186; DOI: 10.1136/thoraxjnl-2012-202212
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
Benjamin David, Mona Bafadhel, Leo Koenderman, Antony De Soyza

Thorax Feb 2021, 76 (2) 188-195; DOI: 10.1136/thoraxjnl-2020-215167
Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis
Manish Pareek, Marion Bond, Jennifer Shorey, Suranjith Seneviratne, Margaret Guy, Peter White, Ajit Lalvani, Onn Min Kon

Thorax Mar 2013, 68 (3) 230-239; DOI: 10.1136/thoraxjnl-2011-201542
Taking airway disease seriously
Pierre Ernst

Thorax Apr 2014, 69 (4) 307-308; DOI: 10.1136/thoraxjnl-2013-204709
Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study
Roland Buhl, Christian Gessner, Wolfgang Schuermann, Karin Foerster, Christian Sieder, Simone Hiltl, Stephanie Korn

Thorax Apr 2015, 70 (4) 311-319; DOI: 10.1136/thoraxjnl-2014-206345
A pro-inflammatory role for the Frizzled-8 receptor in chronic bronchitis
Anita I R Spanjer, Mark H Menzen, Akkelies E Dijkstra, Maarten van den Berge, H Marike Boezen, David C Nickle, Don D Sin, Yohan Bossé, Corry-Anke Brandsma, Wim Timens, Dirkje S Postma, Herman Meurs, Irene H Heijink, Reinoud Gosens

Thorax Apr 2016, 71 (4) 312-322; DOI: 10.1136/thoraxjnl-2015-206958
Statin use and exacerbations in individuals with chronic obstructive pulmonary disease
Truls S Ingebrigtsen, Jacob L Marott, Børge G Nordestgaard, Peter Lange, Jesper Hallas, Jørgen Vestbo

Thorax Jan 2015, 70 (1) 33-40; DOI: 10.1136/thoraxjnl-2014-205795
Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial
Llifon Edwards, Philippa Shirtcliffe, Kirsten Wadsworth, Bridget Healy, Sarah Jefferies, Mark Weatherall, Richard Beasley, on behalf of the Magnesium COPD Study Team

Thorax Apr 2013, 68 (4) 338-343; DOI: 10.1136/thoraxjnl-2012-202225

Main menu

COPD pharmacology

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

COPD pharmacology

Pages